Navigation Links
Degradation of viral DNA in the cell nucleus is opening up new treatment
Date:2/21/2014

Viruses such as HBV can persist by depositing their genetic information (DNA) in the cell nucleus, where the DNA is normally not degraded. This prevents antiviral drugs from eliminating these viruses. But the newly discovered mechanism could make this possible without damaging the infected cell in the liver. In the current issue of the prestigious journal 'Science', the scientists report that now new therapeutic possibilities are consequently opening up.

Although preventive vaccination is possible, the World Health Organization (WHO) reports that more than 240 million people around the world are currently suffering from a chronic hepatitis B infection. They face a high risk of developing liver cirrhosis or even liver cancer. In Germany alone, more than half a million people are affected. Although available antiviral medicines can control the hepatitis B virus, they cannot completely eliminate it. As a result, the HBV in the patient's liver is reactivated as soon as the treatment is discontinued.

This is due to virus DNA (cccDNA: covalently closed circular DNA) "hidden" in the cell nucleus. This virus DNA stores multiple copies of the virus in the nucleus of infected liver cells (hepatocytes) and in this way protects itself from destructive influences. The cccDNA serves as a template for the virus' own proteins and new viral genomes. An international team of scientists headed by Prof. Ulrike Protzer and Prof. Mathias Heikenwlder, Institute of Virology at the Helmholtz Zentrum Mnchen and the Technische Universitt Mnchen, has now found a way to selectively attack and eliminate the viral genetic information in the cell nucleus of the liver cells without damaging the host cell in the process.

"The degradation of viral DNA in the cell nucleus that we describe represents an important mechanism in the defence against the virus", Protzer reports. "Moreover, for the first time, the results offer the possibility to develop a treatment that can heal hepatitis B."

The scientists have discovered that in addition to interferons (the immune system's defence agents), activation of the lymphotoxin β receptor in the host cell promotes certain proteins and supports their function in such a way that they chemically modulate and degrade viral cccDNA. This keeps the virus from reactivating, and also prevents the disease from breaking out again, even after the treatment has ended.

On the other hand, the proteins do not influence the genetic information of the host cell itself, which here is the liver cell. "With the activation of the lymphotoxin β receptor, also combined with substances that are already available, we have a very promising new therapy concept available", Heikenwlder explains.


'/>"/>

Contact: Ulrike Protzer
protzer@helmholtz-muenchen.de
49-894-140-6886
Helmholtz Zentrum Mnchen - German Research Center for Environmental Health
Source:Eurekalert

Related biology news :

1. Streams show signs of degradation at earliest stages of urban development
2. Scientists discover new way protein degradation is regulated
3. Pollination, land degradation: Top priorities for assessment by new UN intergovernmental body
4. Loss of biodiversity limits toxin degradation
5. Discovery offers insight into treating viral stomach flu
6. Women & Infants participating in study of treatment of common viral infection in pregnancy
7. Vitamin D supplements may protect against viral infections during the winter
8. The physics of going viral
9. New study shows promise in using RNA nanotechnology to treat cancers and viral infections
10. Viral alliances overcoming plant defenses
11. Protein production: Going viral
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/7/2018)... ... August 06, 2018 , ... Passersby can’t ... at Southern Illinois University Edwardsville’s University Park. SIUE students are working the “Feedstock ... sorghum. These three feedstocks represent conventional biofuels production, advanced biofuels production and cellulosic ...
(Date:8/7/2018)... SOUTH JORDAN, Utah (PRWEB) , ... August 07, 2018 , ... ... collaboration solutions, announced today their new CT Cloud Voice and SIP solutions. CT ... a scalable and secure, quality voice solution that is far superior to traditional PBX ...
(Date:8/2/2018)... ... August 02, 2018 , ... RxS ... and biotech companies, today announced that Mark Jara, principal of the organization, has ... the life sciences industry. Individuals named to PharmaVOICE 100 are leaders who drive ...
Breaking Biology News(10 mins):
(Date:8/9/2018)... , ... August 09, 2018 , ... ... architectural, engineering, and construction (AEC) experts with building owners and managers for a ... fourth-annual Create + Construct symposium comes to Boston for the first time on ...
(Date:7/31/2018)... ... 2018 , ... ZeptoMetrix™ Corporation (ZMC) announced today ... CE/IVD product inventory. , “We are pleased today to introduce two Group B ... committed to fully support and provide our diagnostics industry with as many precise ...
(Date:7/25/2018)... LAKE GENEVA, Wis. (PRWEB) , ... July 25, ... ... the impact of a biofield energy treated proprietary nutraceutical to combat inflammation and ... inflammation, as well as, immune function response. The following data was reported:, ...
(Date:7/24/2018)... OMAHA, Neb. (PRWEB) , ... July 23, 2018 ... ... the impact of a biofield energy treated nutraceutical to increase immunity and improve ... well as, immune function response assessed in the preclinical research were significantly reduced. ...
Breaking Biology Technology: